WEDNESDAY, Oct. 24 (HealthDay News) -- Fycompa (perampanel) tablets have been approved by the U.S. Food and Drug Administration to treat partial onset seizures in people aged 12 and older who have epilepsy.
The most common side effects of Fycompa reported during clinical trials included dizziness, sleepiness, irritability, falls, upper respiratory infections, and weight gain.
Fycompa's label warns of the possibility of more serious side effects, including aggression, anger, anxiety, paranoia, euphoria and agitation.
The drug is produced by Eisai Inc., of Woodcliff Lake, N.J.
The U.S. National Library of Medicine has more about epilepsy.
Copyright © 2012 HealthDay. All rights reserved.
|Previous: Terminal Cancer Patients May Have Erroneous Chemo Beliefs||Next: Two Face-Selective Regions ID'd in the Fusiform Gyrus|
Reader comments on this article are listed below. Review our comments policy.